Pitney Bowes reports tomorrow morning with one clear theme defining the week: short sellers have been quietly covering, even as the stock drifts lower.
Short interest has fallen to 10.7% of the free float, down from roughly 12% in late June. That is still a meaningfully elevated position — about 17.3 million shares short according to ORTEX's daily estimate — but the direction of travel is unambiguous. Shorts have trimmed by nearly 4% over the past week and by almost 4% over the prior month. FINRA's fortnightly figure, settled as of July 15, shows 17.5 million shares short with a days-to-cover ratio of 8.1, confirming the elevated but gently easing picture. Borrow conditions back up the cautious-but-not-aggressive read. Cost to borrow has fallen sharply — down roughly 27% on the week to just 0.45% — and availability is ample at nearly 758% of short interest, well above the 52-week floor of 200%. The lending market is relaxed; this is not a stock where bears face any squeeze pressure heading into the number.
Options positioning tells a similar story. Call open interest clearly dominates, with the put/call ratio at 0.20 — fractionally below its 20-day average of 0.21, and running near the bottom half of the 52-week range (high 0.24, low 0.15). The z-score is marginally negative at -0.81, meaning options traders are slightly more constructive than their recent norm. There is no defensive hedging spike ahead of tomorrow's release.
The Street is modestly optimistic, though coverage remains thin and a degree of staleness applies to the consensus. Four analysts hold the stock at "hold," with a mean price target of $17.14 — a fraction below the current $17.83 price, which is consistent with the multiple picture: PBI trades at 10.5x trailing earnings and 7.7x EV/EBITDA, both of which have nudged lower over the past month. The most notable recent action came from B of A Securities in mid-May, when the firm upgraded from Underperform to Neutral and lifted its target from $9.50 to $16.50 — a dramatic reversal that reflected the stock's sharp re-rating after it emerged from financial restructuring. Citizens has since pushed its target to $19 on a Market Outperform rating. The factor picture is mixed: PBI scores in the 95th percentile on dividend yield, and ranks strongly on EV/EBIT (81st percentile), but forward earnings growth looks weak — 12-month forward EPS year-on-year sits in the 13th percentile — and the short score, at 58.6, has been drifting slightly higher all week, suggesting ORTEX's composite model sees a modest incremental short case building even as headline SI falls.
The ownership picture adds an important wrinkle. Hestia Capital Management, which holds a board seat and was previously a major activist shareholder, has sold heavily since early June — over 1 million shares across multiple tranches at prices from $16.83 to $17.40, representing roughly $14 million in gross proceeds. The firm's reported holding has fallen from nearly 7.8 million shares to 2.9 million. That is a significant reduction by a board-affiliated insider, and it has been the dominant insider-activity signal across the 90-day window. Net insider sales over 90 days total more than 3.6 million shares. Hestia's continued exit deserves attention from anyone assessing conviction among those closest to the restructuring story.
Earnings history at PBI has not set a dramatic pattern. The two prior prints with available data show modest negative reactions: a 3.5% one-day drop after the May 12 report and a 1.5% decline after the May 5 event. Neither produced a meaningful five-day follow-through in either direction. The question heading into tomorrow is less about short-term positioning — which looks neutral to slightly long-leaning — and more about whether management can show the Presort and SendTech segments are stabilising revenue in the face of secular mail-volume decline, and what Hestia's continued reduction signals about the trajectory of the restructuring.
See the live data behind this article on ORTEX.
Open PBI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
